Filter
1156
Filtered Results: 1156
Text search:
variants
Featured
Recommendations
124
New Publications
150
Language
Document type
No document type
395
Studies & Reports
246
Guidelines
244
Fact sheets
80
Strategic & Response Plan
56
Manuals
52
Situation Updates
23
Training Material
19
Videos
17
Resource Platforms
12
Infographics
6
Brochures
5
Online Courses
1
Countries / Regions
Global
51
Germany
36
India
34
Brazil
33
Africa
33
Latin America and the Carribbean
31
Senegal
27
Western and Central Europe
26
Congo, Democratic Republic of
20
Burkina Faso
15
South Africa
15
Venezuela
14
Kenya
13
Central African Republic
13
West and Central Africa
12
Russia
12
Ethiopia
10
Benin
10
Argentina
10
Colombia
10
Nigeria
9
Syria
9
Rwanda
9
Malawi
9
Peru
9
East and Southern Africa
9
Eastern Europe
9
Haiti
8
South Sudan
8
Mozambique
8
Ukraine
8
Madagascar
8
Middle East and North Africa
8
Niger
7
Philippines
7
Cameroon
6
Uganda
6
Togo
6
Bolivia
6
Myanmar / Burma
6
Guinea
5
Ghana
5
Ecuador
5
Chile
5
Eastern Europe and Central Asia
5
Paraguay
5
Liberia
4
Zimbabwe
4
Iraq
4
Bangladesh
4
Guatemala
4
Spain
4
Morocco
3
Lebanon
3
Chad
3
Indonesia
3
South–East Asia Region
3
Asia
3
Sierra Leone
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Afghanistan
2
Turkey
2
Cambodia
2
China
2
Sudan
2
El Salvador
2
Angola
2
Nicaragua
2
Yemen
2
Western Pacific Region
2
Tajikistan
2
Moldova
2
Uzbekistan
2
Kazakhstan
2
France
2
Tunisia
2
Portugal
2
Belarus
2
Guinea-Bissau
1
Saudi Arabia
1
Somalia
1
Nepal
1
Pakistan
1
Jordan
1
Zambia
1
Egypt
1
Tanzania
1
Mauritania
1
Dominican Republic
1
Namibia
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Cuba
1
Burundi
1
Honduras
1
Libya
1
Mexico
1
Palestine
1
Italy
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Estonia
1
Iran
1
Kyrgyzstan
1
Georgia
1
Vietnam
1
Gabon
1
Jamaica
1
United Kingdom
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
408
Clinical Guidelines
84
Public Health
53
Key Resources
31
Women & Child Health
27
Pharmacy & Technologies
23
Capacity Building
10
Annual Report MEDBOX
1
Toolboxes
COVID-19
384
Mental Health
101
HIV
42
TB
39
Rapid Response
38
Planetary Health
34
Refugee
31
NTDs
29
AMR
25
Global Health Education
24
Ebola
21
NCDs
20
Health Financing Toolbox
16
Caregiver
15
Disability
13
Conflict
13
Pharmacy
12
Cholera
9
Natural Hazards
8
Specific Hazards
6
Polio
5
Social Ethics
4
Zika
3
South Sudan
1
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only together can they provide essential information to ...
The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for
surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing
event-based surveillance (EBS) using a multisectoral, One Health approach. To ...
Le cadre de surveillance basé sur les événements est destiné à être utilisé par les autorités et les
agences responsables de la surveillance et de l'intervention. Ce cadre sert de cadre pour guider les
parties prenantes intéressées par la mise en œuvre de la surveillance basée sur le...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
Rebuilding Liberia’s health system is crucial for improving the country’s overall health outcomes. This annual report highlights key achievements, challenges,and lessons learned in implementing programmes of technical cooperation with the Government of Liberia from January to December 2022. T...
The overall objective of the framework is to support WHO and Members States in meaningful engagement of people living with NCDs, and mental health and neurological conditions to co-create and enhance related policies, programmes and services. This framework will contribute to advancing understanding...
L’objectif général de ce cadre est de permettre à l’OMS et à ses États Membres d’assurer la participation significative des personnes vivant avec des maladies non transmissibles, des problèmes de santé mentale et neurologiques, via un processus de cocréation et de renforcement des poli...
The 2023 Country Presence Report provides an overview of what WHO does in countries to advance towards the SDGs and implement GPW13, how we do it, with whom we work, and what is needed to overcome challenges for achieving results and impact in countries.
This Urban Flood Risk Handbook: Assessing Risk and Identifying Interventions is a roadmap for conducting an urban flood risk assessment in any city in the world. It includes practical guidance for a flood risk assessment project, covering the key hazard and risk modeling stages as well as the evalua...
This report analyses the intersection of HIV, COVID-19 and public debt in developing countries. The collision between COVID-19 and a crippling debt crisis have reversed decades of progress - putting present and future investments in health and HIV at risk. Pragmatic options to address the pandemic t...
This paper introduces a new dataset of official financing—including foreign aid and other forms of concessional and non-concessional state financing—from China to 138 countries between 2000 and 2014. We use these data to investigate whether and to what extent Chinese aid affects economic growth ...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current ...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
